Frequency and risk factors of metabolic associated fatty liver disease among medical students in Egypt DOI Creative Commons
Mohamed Mahmoud Elhoseeny,

Fatma Rageh,

Samar M Rezk

et al.

Scientific Reports, Journal Year: 2025, Volume and Issue: 15(1)

Published: April 18, 2025

Abstract Metabolic (dysfunction) associated fatty liver disease (MAFLD) is a growing global concern. This study assessed the frequency of hepatic steatosis and MAFLD, alongside their risk factors, among medical students at Suez University, Egypt. A cross-sectional was conducted from November 2022 to April 2023 84 aged ≥ 18 years. Data on anthropometric parameters, body composition, lifestyle were collected through self-administered questionnaires, InBody analysis, FibroScan. MAFLD diagnosis required (≥ 238 dB/m) with obesity, metabolic dysfunction, or both. Statistical analyses included chi-square tests, ANOVA, logistic regression. Hepatic present in 25% participants, while 13.1%. Participants exhibited higher weight (82.34 ± 10.78 kg vs. 65.84 10.61 kg, p < 0.001), BMI (29.05 3.66 22.90 3.23 kg/m 2 , waist circumference (88.73 8.73 cm 78.10 7.96 cm, BMR (1566.09 27.37 1429.86 93.44 kcal/day, fat mass (32.74 7.25% 23.91 8.60%, 0.001). Binary regression analysis revealed increased weight, BMI, circumference, as significant factors for MAFLD. An elevated percentage reduced muscle highlighted sarcopenic obesity role progression. Extreme reduction can exacerbate accumulation. Poor sleep quality, sedentary lifestyle, an unhealthy diet are also predictors. The widespread highlights pressing need tackle this silent epidemic young Egyptian adults.

Language: Английский

Frequency and risk factors of metabolic associated fatty liver disease among medical students in Egypt DOI Creative Commons
Mohamed Mahmoud Elhoseeny,

Fatma Rageh,

Samar M Rezk

et al.

Scientific Reports, Journal Year: 2025, Volume and Issue: 15(1)

Published: April 18, 2025

Abstract Metabolic (dysfunction) associated fatty liver disease (MAFLD) is a growing global concern. This study assessed the frequency of hepatic steatosis and MAFLD, alongside their risk factors, among medical students at Suez University, Egypt. A cross-sectional was conducted from November 2022 to April 2023 84 aged ≥ 18 years. Data on anthropometric parameters, body composition, lifestyle were collected through self-administered questionnaires, InBody analysis, FibroScan. MAFLD diagnosis required (≥ 238 dB/m) with obesity, metabolic dysfunction, or both. Statistical analyses included chi-square tests, ANOVA, logistic regression. Hepatic present in 25% participants, while 13.1%. Participants exhibited higher weight (82.34 ± 10.78 kg vs. 65.84 10.61 kg, p < 0.001), BMI (29.05 3.66 22.90 3.23 kg/m 2 , waist circumference (88.73 8.73 cm 78.10 7.96 cm, BMR (1566.09 27.37 1429.86 93.44 kcal/day, fat mass (32.74 7.25% 23.91 8.60%, 0.001). Binary regression analysis revealed increased weight, BMI, circumference, as significant factors for MAFLD. An elevated percentage reduced muscle highlighted sarcopenic obesity role progression. Extreme reduction can exacerbate accumulation. Poor sleep quality, sedentary lifestyle, an unhealthy diet are also predictors. The widespread highlights pressing need tackle this silent epidemic young Egyptian adults.

Language: Английский

Citations

0